Inogen (INGN) Preferred Dividend Payments (2013 - 2026)
Inogen's (INGN) quarterly Preferred Dividend Payments came in at -$164000.0 in Q2 2026, down 127.06% year-over-year from $606000.0 in Q2 2025, and down 343.24% quarter-over-quarter from -$37000.0 in Q1 2026.
Analysis
Inogen (INGN) Preferred Dividend Payments (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Preferred Dividend Payments for 6 consecutive years, with -$164000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Preferred Dividend Payments fell 127.06% year-over-year to -$164000.0 in Q2 2026; TTM through Jun 2026 was $1.0 million, a 1875.86% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 708.02% from the prior year.
- Preferred Dividend Payments was -$164000.0 for Q2 2026 at Inogen, down from -$37000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $652000.0 in Q3 2025 and troughed at -$784000.0 in Q4 2022.
- A 4-year average of -$8800.0 and a median of -$25000.0 in 2023 frame the typical range for Preferred Dividend Payments.
- Across the five-year window, Preferred Dividend Payments sank 559.09% in 2022 and sank 127.06% in 2026, its largest moves.
- Over 4 years, Preferred Dividend Payments stood at -$784000.0 in 2022, then jumped by 98.34% to -$13000.0 in 2023, then surged by 4553.85% to $579000.0 in 2025, then sank by 128.32% to -$164000.0 in 2026.
- The last three Preferred Dividend Payments figures came in at -$164000.0 (Q2 2026), -$37000.0 (Q1 2026), and $579000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | -164,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -164,000.00 |
| Mar 31, 2026 | -37,000.00 |
| Dec 31, 2025 | 579,000.00 |
| Sep 30, 2025 | 652,000.00 |
| Jun 30, 2025 | 606,000.00 |
| Mar 31, 2025 | 133,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Dec 31, 2022 | -784,000.00 |
| Jun 30, 2022 | -606,000.00 |
| Mar 31, 2022 | -454,000.00 |
| Dec 31, 2021 | -314,000.00 |
| Sep 30, 2021 | -106,000.00 |
| Jun 30, 2021 | 132,000.00 |
| Mar 31, 2021 | 241,000.00 |
| Jun 30, 2013 | 175,000.00 |